642 related articles for article (PubMed ID: 15341544)
1. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
[TBL] [Abstract][Full Text] [Related]
3. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease.
Bruandet A; Richard F; Bombois S; Maurage CA; Deramecourt V; Lebert F; Amouyel P; Pasquier F
J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):133-9. PubMed ID: 18977819
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of donepezil treatment in Alzheimer patients with and without subcortical vascular lesions.
Blasko I; Bodner T; Knaus G; Walch T; Monsch A; Hinterhuber H; Marksteiner J
Pharmacology; 2004 Sep; 72(1):1-5. PubMed ID: 15292648
[TBL] [Abstract][Full Text] [Related]
6. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
[TBL] [Abstract][Full Text] [Related]
7. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
Bidzan M; Bidzan L
Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769
[TBL] [Abstract][Full Text] [Related]
8. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
[TBL] [Abstract][Full Text] [Related]
9. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
[TBL] [Abstract][Full Text] [Related]
10. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
Jellinger KA; Attems J
Acta Neurol Scand; 2006 Jul; 114(1):38-46. PubMed ID: 16774626
[TBL] [Abstract][Full Text] [Related]
12. Clinical and neuropsychological features in autopsy-defined vascular dementia.
Reed BR; Mungas DM; Kramer JH; Betz BP; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
Clin Neuropsychol; 2004 Feb; 18(1):63-74. PubMed ID: 15595359
[TBL] [Abstract][Full Text] [Related]
13. Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
Malek-Ahmadi M; Perez SE; Chen K; Mufson EJ
J Alzheimers Dis; 2020; 74(1):189-197. PubMed ID: 31985469
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impact of subcortical vascular and Alzheimer's disease pathology.
Chui HC; Zarow C; Mack WJ; Ellis WG; Zheng L; Jagust WJ; Mungas D; Reed BR; Kramer JH; Decarli CC; Weiner MW; Vinters HV
Ann Neurol; 2006 Dec; 60(6):677-87. PubMed ID: 17192928
[TBL] [Abstract][Full Text] [Related]
15. Smell identification function as a severity and progression marker in Alzheimer's disease.
Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
[TBL] [Abstract][Full Text] [Related]
16. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
[TBL] [Abstract][Full Text] [Related]
17. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.
Lim A; Tsuang D; Kukull W; Nochlin D; Leverenz J; McCormick W; Bowen J; Teri L; Thompson J; Peskind ER; Raskind M; Larson EB
J Am Geriatr Soc; 1999 May; 47(5):564-9. PubMed ID: 10323650
[TBL] [Abstract][Full Text] [Related]
18. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
Jellinger KA
Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
[TBL] [Abstract][Full Text] [Related]
19. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
